
Phase Ib Open Clinical Trial to Assess the Safety of Autologous Mesenchymal Stem Cells for the Treatment of Nonrevascularizable Critical Lower Limb Ischemia
Author(s) -
Riera del Moral L,
Salazar Álvarez A,
Stefanov Kiuri S,
Haijiang Tong,
Riera de Cubas L,
Damián GarcíaOlmo,
Mariano García-Arranz
Publication year - 2017
Publication title -
journal of stem cell research and therapy
Language(s) - English
Resource type - Journals
ISSN - 2157-7633
DOI - 10.4172/2157-7633.1000391
Subject(s) - mesenchymal stem cell , critical limb ischemia , clinical trial , medicine , stem cell , ischemia , bioinformatics , surgery , pathology , biology , vascular disease , microbiology and biotechnology , arterial disease